106 related articles for article (PubMed ID: 27173373)
1. Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle Glaucoma.
Schultz NM; Wong WB; Coleman AL; Malone DC
Am J Ophthalmol; 2016 Aug; 168():78-85. PubMed ID: 27173373
[TBL] [Abstract][Full Text] [Related]
2. Topical prostaglandin analogues do not affect selective laser trabeculoplasty outcomes.
Singh D; Coote MA; O'Hare F; Walland MJ; Ghosh S; Xie J; Ruddle JB; Crowston JG
Eye (Lond); 2009 Dec; 23(12):2194-9. PubMed ID: 19182767
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea.
Choi JA; Song LD; Choi S; Park SM; Kwon JW; Jee D
Medicine (Baltimore); 2019 Jan; 98(2):e14026. PubMed ID: 30633194
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication: A Population-Based Study.
Quinn MP; Johnson D; Whitehead M; Gill SS; Campbell RJ
Ophthalmol Glaucoma; 2021; 4(4):358-364. PubMed ID: 33358187
[TBL] [Abstract][Full Text] [Related]
5. Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma.
Berdahl JP; Khatana AK; Katz LJ; Herndon L; Layton AJ; Yu TM; Bauer MJ; Cantor LB
J Med Econ; 2017 Jul; 20(7):760-766. PubMed ID: 28471282
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Resource Use and Costs of Caring for Patients With Exfoliation Syndrome Glaucoma Versus Primary Open-Angle Glaucoma.
Rathi S; Andrews C; Greenfield DS; Stein JD
Am J Ophthalmol; 2019 Apr; 200():100-109. PubMed ID: 30629910
[TBL] [Abstract][Full Text] [Related]
7. Variations in treatment among adult-onset open-angle glaucoma patients.
Friedman DS; Nordstrom B; Mozaffari E; Quigley HA
Ophthalmology; 2005 Sep; 112(9):1494-9. PubMed ID: 16019072
[TBL] [Abstract][Full Text] [Related]
8. Selective laser trabeculoplasty for early glaucoma: analysis of success predictors and adjusted laser outcomes based on the untreated fellow eye.
Chun M; Gracitelli CP; Lopes FS; Biteli LG; Ushida M; Prata TS
BMC Ophthalmol; 2016 Nov; 16(1):206. PubMed ID: 27881155
[TBL] [Abstract][Full Text] [Related]
9. A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand.
Ngan K; Fraser E; Buller S; Buller A
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2181-2189. PubMed ID: 30132278
[TBL] [Abstract][Full Text] [Related]
10. Healthcare charges in patients with glaucoma who undergo laser trabeculoplasty.
Pasquale LR; Walt JG; Stern LS; Wiederkehr D; Malangone E; Dolgitser M
Adv Ther; 2009 Dec; 26(12):1084-96. PubMed ID: 20077051
[TBL] [Abstract][Full Text] [Related]
11. Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study.
Coleman AL; Lum FC; Velentgas P; Su Z; Gliklich RE;
J Comp Eff Res; 2016 Jan; 5(1):79-85. PubMed ID: 26691017
[TBL] [Abstract][Full Text] [Related]
12. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
[TBL] [Abstract][Full Text] [Related]
13. Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization.
Trese MGJ; Lewis AW; Blachley TS; Stein JD; Moroi SE
J Ocul Pharmacol Ther; 2017 Oct; 33(8):591-597. PubMed ID: 28854348
[TBL] [Abstract][Full Text] [Related]
14. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan.
Lee R; Hutnik CM
Can J Ophthalmol; 2006 Aug; 41(4):449-56. PubMed ID: 16883360
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US.
Cantor LB; Katz LJ; Cheng JW; Chen E; Tong KB; Peabody JW
Curr Med Res Opin; 2008 Oct; 24(10):2905-18. PubMed ID: 18768105
[TBL] [Abstract][Full Text] [Related]
16. Selective laser trabeculoplasty as a replacement for medical therapy in open-angle glaucoma.
Francis BA; Ianchulev T; Schofield JK; Minckler DS
Am J Ophthalmol; 2005 Sep; 140(3):524-5. PubMed ID: 16139003
[TBL] [Abstract][Full Text] [Related]
17. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma.
Juzych MS; Chopra V; Banitt MR; Hughes BA; Kim C; Goulas MT; Shin DH
Ophthalmology; 2004 Oct; 111(10):1853-9. PubMed ID: 15465546
[TBL] [Abstract][Full Text] [Related]
18. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.
Jayawant SS; Bhosle MJ; Anderson RT; Balkrishnan R
J Glaucoma; 2007 Sep; 16(6):513-20. PubMed ID: 17873711
[TBL] [Abstract][Full Text] [Related]
19. Selective laser trabeculoplasty compared with medical treatment for the initial management of open angle glaucoma or ocular hypertension.
Pérez E; Rada G; Maul E
Medwave; 2015 Dec; 15 Suppl 3():e6337. PubMed ID: 26730963
[TBL] [Abstract][Full Text] [Related]
20. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
